fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

New findings on bacteria that increase risk of pancreatic cancer

Written by | 12 Dec 2021

Bacteria from the digestive system seem to have the potential to cause damage to pancreatic cells, increasing the risk of malignant tumours. Now for the first time, live… read more.

Dupilumab reduces attacks and improves lung function in asthmatic children

Written by | 12 Dec 2021

The biologic drug dupilumab lowers the rate of severe asthma attacks and improves lung function and asthma control for children ages 6 to 11, researchers reported on December 9, 2021 in… read more.

Breakthrough in understanding motor neuron disease

Written by | 11 Dec 2021

Researchers at Trinity College Dublin have made a major discovery in understanding motor neuron disease (MND). The research team has found that MND has 4 distinct patterns of… read more.

Acurable receives FDA 510(k) clearance for its home sleep apnoea testing device

Written by | 11 Dec 2021

AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect obstructive sleep apnoea (OSA) in adults, has obtained FDA clearance as a Class II… read more.

Statin use affects prostate cancer screening results

Written by | 10 Dec 2021

Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study conducted at Tampere University in Finland finds. In statin users, screening did… read more.

Molnupiravir – what you need to know

Written by | 10 Dec 2021

Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at… read more.

Aspaveli receives positive CHMP opinion for treatment of paroxysmal nocturnal haemoglobinuria – SOBI + Apellis Pharma

Written by | 9 Dec 2021

Swedish Orphan Biovitrum AB (publ) (Sobi) and Apellis Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted… read more.

Pharmacogenomic testing in children: practicalities and implications

Written by | 9 Dec 2021

A pharmacogenomic testing service involves more than simply reporting that a patient has a genetic variant that affects the way they respond to a drug. In a session… read more.

How the superbug Pseudomonas aeruginosa reacts to antibiotics

Written by | 8 Dec 2021

The bacterium Pseudomonas aeruginosa is resistant to all antibiotics on the market. Therefore, there is a great need for new therapeutic approaches. In order to find them, it… read more.

Dexamethasone treatment increases survival in some cancers

Written by | 8 Dec 2021

Patients with certain types of cancer appear to have better survival rates if they are treated during surgery with the anti-nausea drug dexamethasone. The finding was reported on… read more.

Scientists discover potential cause of Alzheimer’s Disease

Written by | 7 Dec 2021

Existing drugs may offer effective treatment. Prevailing theories posit plaques in the brain cause Alzheimer’s disease. New UC Riverside research points to cells’ slowing ability to clean themselves… read more.

ASHP distinguished leadership awards

Written by | 7 Dec 2021

At the opening session of the 2021 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting awards for excellence in pharmacy practice leadership were made to two ASHP… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.